164 related articles for article (PubMed ID: 33556668)
1. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
[TBL] [Abstract][Full Text] [Related]
2. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
[TBL] [Abstract][Full Text] [Related]
4. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
[TBL] [Abstract][Full Text] [Related]
6. Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis.
Li H; Wang CC; Zhang M; Li XL; Zhang P; Yue LT; Miao S; Wang S; Liu Y; Li YB; Duan RS
Mol Cell Neurosci; 2015 Sep; 68():284-92. PubMed ID: 26311508
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.
Zhang P; Yang CL; Liu RT; Li H; Zhang M; Zhang N; Yue LT; Wang CC; Dou YC; Duan RS
Mol Immunol; 2018 Feb; 94():200-208. PubMed ID: 29331804
[TBL] [Abstract][Full Text] [Related]
8. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
[TBL] [Abstract][Full Text] [Related]
9. ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
Liu RT; Zhang P; Yang CL; Pang Y; Zhang M; Zhang N; Yue LT; Li XL; Li H; Duan RS
J Neuroimmunol; 2017 Oct; 311():71-78. PubMed ID: 28844501
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.
Yao X; Kong Q; Xie X; Wang J; Li N; Liu Y; Sun B; Li Y; Wang G; Li W; Qu S; Zhao H; Wang D; Liu X; Zhang Y; Mu L; Li H
Immunology; 2014 Nov; 143(3):396-405. PubMed ID: 24850614
[TBL] [Abstract][Full Text] [Related]
11. Targeting HIF-1α alleviates the inflammatory responses and rebuilds the CD4
Yu L; Ran H; Lu Y; Ma Q; Huang H; Liu W
Life Sci; 2024 Jan; 336():122287. PubMed ID: 37995933
[TBL] [Abstract][Full Text] [Related]
12. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.
Zhang P; Yang CL; Du T; Liu YD; Ge MR; Li H; Liu RT; Wang CC; Dou YC; Duan RS
J Neuroinflammation; 2021 Oct; 18(1):244. PubMed ID: 34702288
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental autoimmune myasthenia gravis rats with FTY720 and its effect on Th1/Th2 cells.
Huang J; Zhang T; Wang H; Zhao Y
Mol Med Rep; 2018 May; 17(5):7409-7414. PubMed ID: 29568889
[TBL] [Abstract][Full Text] [Related]
15. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.
Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H
Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344
[TBL] [Abstract][Full Text] [Related]
16. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway.
Lu Y; Ma Q; Yu L; Huang H; Liu X; Chen P; Ran H; Liu W
Int Immunopharmacol; 2023 Feb; 115():109693. PubMed ID: 36638660
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
[TBL] [Abstract][Full Text] [Related]
18. Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.
Wang CC; Li H; Zhang M; Li XL; Yue LT; Zhang P; Zhao Y; Wang S; Duan RN; Li YB; Duan RS
J Neuroinflammation; 2015 Jun; 12():118. PubMed ID: 26071315
[TBL] [Abstract][Full Text] [Related]
19. AEB-071 Ameliorates Muscle Weakness by Altering Helper T Lymphocytes in an Experimental Autoimmune Myasthenia Gravis Rat Model.
Jing F; Huang W; Ma Q; Xu SJ; Wu CJ; Guan YX; Chen B
Med Sci Monit; 2020 Sep; 26():e924393. PubMed ID: 32920588
[TBL] [Abstract][Full Text] [Related]
20. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
